Expertise in
10
conditions

Hiroyoshi Suzuki

Sakura, JP 
Expertise in
10
conditions
Sakura, JP 

Overview

Hiroyoshi Suzuki practices practicing medicine in Sakura, Japan.

Suzuki is highly rated in 10 conditions, according to our data. Their clinical expertise encompasses Prostate Cancer, Dysembryoplastic Neuroepithelial Tumors (DNET), Hyperaldosteronism, Lithotripsy, and Prostatectomy.

They are actively involved in clinical research, co-authoring 376 peer reviewed articles and participating in 3 clinical trials.

Locations

Sakura, 2858741, Japan
Other Locations
Sakura, 2858741, Japan
Okawara, Japan
Japan
Sendai, Japan
Sapporo, 0600818, Japan
Mito, Japan
Tobo, Japan
Gifu-shi, Japan
Osaka, Japan
Wakayama, Japan
Chiba, 2858741, Japan
Inashiki, 3000393, Japan
Showamachi, Japan
Komaki, 4850852, Japan
Maebashi, 3718511, Japan
Chuo, 2608670, Japan
St Marianna University School of Medicine
Kawasaki, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Study Phase: Phase 2/Phase 3
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Drug
Study Phase: Phase 3
A Phase 1 Study of Abemaciclib in Combination With Other Anti-Cancer Therapy in Japanese Patients With Advanced Cancer
A Phase 1 Study of Abemaciclib in Combination With Other Anti-Cancer Therapy in Japanese Patients With Advanced Cancer
Enrollment Status: Completed
Publish Date: September 21, 2021
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

376 Total Publications

Darolutamide With Concomitant Lipid-Modifying Agents in Nonmetastatic Castration-Resistant Prostate Cancer.
Darolutamide With Concomitant Lipid-Modifying Agents in Nonmetastatic Castration-Resistant Prostate Cancer.
Journal: JAMA network open
Published: August 19, 2026

Frequently Asked Questions about Hiroyoshi Suzuki

Is Hiroyoshi Suzuki a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Hiroyoshi Suzuki is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hiroyoshi Suzuki participate in research or clinical trials?

Yes. Hiroyoshi Suzuki has published 376 articles and abstracts on conditions like Prostate Cancer. You can view a list of Hiroyoshi Suzuki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Suzuki's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 67 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile